1. Home
  2. GETY vs ARQT Comparison

GETY vs ARQT Comparison

Compare GETY & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GETY
  • ARQT
  • Stock Information
  • Founded
  • GETY 1995
  • ARQT 2016
  • Country
  • GETY United States
  • ARQT United States
  • Employees
  • GETY N/A
  • ARQT N/A
  • Industry
  • GETY Industrial Machinery/Components
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • GETY Industrials
  • ARQT Health Care
  • Exchange
  • GETY Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • GETY 941.4M
  • ARQT 1.1B
  • IPO Year
  • GETY N/A
  • ARQT 2020
  • Fundamental
  • Price
  • GETY $2.83
  • ARQT $13.08
  • Analyst Decision
  • GETY Buy
  • ARQT Strong Buy
  • Analyst Count
  • GETY 5
  • ARQT 5
  • Target Price
  • GETY $5.61
  • ARQT $17.00
  • AVG Volume (30 Days)
  • GETY 5.8M
  • ARQT 2.0M
  • Earning Date
  • GETY 03-13-2025
  • ARQT 02-25-2025
  • Dividend Yield
  • GETY N/A
  • ARQT N/A
  • EPS Growth
  • GETY N/A
  • ARQT N/A
  • EPS
  • GETY 0.13
  • ARQT N/A
  • Revenue
  • GETY $917,902,000.00
  • ARQT $138,708,000.00
  • Revenue This Year
  • GETY $4.33
  • ARQT $209.03
  • Revenue Next Year
  • GETY $1.96
  • ARQT $49.00
  • P/E Ratio
  • GETY $21.07
  • ARQT N/A
  • Revenue Growth
  • GETY N/A
  • ARQT 182.84
  • 52 Week Low
  • GETY $2.06
  • ARQT $3.59
  • 52 Week High
  • GETY $5.77
  • ARQT $16.20
  • Technical
  • Relative Strength Index (RSI)
  • GETY 55.25
  • ARQT 46.24
  • Support Level
  • GETY $2.28
  • ARQT $12.61
  • Resistance Level
  • GETY $2.79
  • ARQT $14.36
  • Average True Range (ATR)
  • GETY 0.26
  • ARQT 0.98
  • MACD
  • GETY 0.07
  • ARQT -0.32
  • Stochastic Oscillator
  • GETY 42.38
  • ARQT 13.09

About GETY Getty Images Holdings Inc.

Getty Images Holdings Inc is engaged in the core mission of bringing the world's creative and editorial visual content solutions to its customers to engage their audiences. the company has developed market enhancements across e-commerce, content subscriptions, user-generated content, diverse and inclusive content, and proprietary research alongside investment in its technology platform, which includes artificial intelligence and machine learning-driven search functionality and image editing and integrated APIs, to become a trusted industry leader in the visual content. Geographically the company operates in the Americas, Europe, the Middle East, Africa, and Asia-Pacific, out of which a majority of its revenue is generated from the Americas.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: